In this week’s issue:
- The March 2015 CIHR Translational Open Operating Grant registration deadline is today, Friday January 9th. A new CV format is required for this competition. Details available at http://www.cihr-irsc.gc.ca/e/48878.html?utm_source=cihr&utm_medium=rss&utm_campaign=cihr_rss&utm_reader=feedly.
- CIHR Foundation Scheme Stage 2 application procedures will be announced next week.
- Citizens United for Research in Epilepsy – 2015 Grant Cycle
- Willis-Ekbom Disease Foundation – 2015 Grant Program
- American Institute for Cancer Research – Investigator-Initiated Grants
- Simons Foundation – Novel Outcome Measures for ASD Clinical Trials
- Leukemia & Lymphoma Society – Translational Research Program
- Women’s Health Research Institute – Nelly Auersperg Award (reminder)
- Friedreich’s Ataxia Research Alliance – Phillip Bennet and Kyle Bryant Translational Research Award
- PSC Partners Seeking A Cure – Research Grants
Awards and Honours:
- Michael Smith Foundation for Health Research – Aubrey J. Tingle Prize
- Medical Council of Canada – Dr. Louis Levasseur Distinguished Service Award
- BC Cancer Agency Research Seminar – “Cancer Genomics: From Discovery to Clinic”
- SPARC Office – NSERC Strategic Project Grants Workshop
- Brain Talks UBC – Robotics and Rehabilitation
LOI Deadline: January 15, 2015
Citizens United for Research in Epilepsy (CURE) is accepting LOIs for its first 2015 grant cycle. Available opportunities include:
- Sudden Unexpected Death in Epilepsy Award
- Challenge Award
- Prevention of Acquired Epilepsies Award
- Pediatric Epilepsies Award
All awards are $250,000 paid over 2 years. Please visit the CURE website for more information on these awards.
LOI Deadline: January 16, 2015
The Willis-Ekbom Disease Foundation aspires to achieve universal awareness, identify effective treatments, and find the cure for the millions of men, women, and children who suffer from WED, or restless leg syndrome, a distinctive but often misdiagnosed sensorimotor disorder that affects more than 5 percent of the population.
Primary features of WED include paresthesias deep in the limbs that compel the person to move in order to relieve the sensations that occur when the afflicted individual is at rest, primarily in the evening and at night. Associated features include the presence of periodic limb movements during sleep, sleep disturbance (leading to daytime sleepiness), a positive family history, a progressive disease course, and the lack of another medical condition that accounts for the symptoms.
In 2015, the foundation will award two grants of up to $35,000 each to support hypothesis-driven research related to effective treatments of WED.
Applicants need not be members of academic institutions. Scientists in biotech companies are encouraged to apply for funds that will allow them to seed relevant projects and obtain SBIR grants if necessary. Multi-institutional collaborations are encouraged.
Letters of Intent must be received no later than January 19, 2015. Upon review, selected applicants will be invited to submit full proposals by April 3, 2015.
For complete program guidelines, information about previous award recipients, and application procedures, visit the WED Foundation website.
LOI Deadline: January 26, 2015
The American Institute for Cancer Research is now accepting Letters of Intent for Investigator-Initiated Grants for the 2015 Grant Cycle. Please share this information with interested colleagues.
AICR’s Grant Program is dedicated to funding research on cancer prevention, treatment and survival through food, nutrition, physical activity and weight management (body fatness). Grant applications must adhere to AICR’s general research principles and be clearly related to at least one of AICR’s research themes (see sections 3.2 and 3.3 of the AICR Grant Application Package). Preference will be given to applications that have direct relevance to human cancer.
To download the Grant Application Package, for instructions on how to apply online for a grant, and for more information about our grant program, please visit the AICR website.
Questions? Contact the AICR Research Department at email@example.com or 800-843-8114.
Notice of Intent Deadline: February 5, 2015
Application Deadline: February 23, 2015; 2pm
The mission of the Simons Foundation Autism Research Initiative is to improve the diagnosis and treatment of autism spectrum disorders.
Through its 2015 Novel Outcome Measures for ASD Clinical Trials, the foundation will award grants of up to $500,000 over two years for research that aims to develop and validate objective outcome measures for use in clinical trials targeting core symptoms (social communication impairments and restricted, repetitive behaviors) of autism spectrum disorder, as well as disruptive behavioral symptoms commonly reported in individuals with autism (e.g., anxiety, tantrums).
Priority will be given to projects that measure behaviors, skills, or biomarkers that have relevance to one or more core autism domains of socialization, language, and repetitive behavior, and that co-vary with autism severity; are objective and yield continuous quantitative data of sufficient range; are feasible in terms of burden on participants and families; capture data (when possible) from participants in their natural environment rather than exclusively in the laboratory setting; and are scalable and affordable for large clinical trials (e.g., between three hundred and a thousand participants).
Examples of possible approaches include but are not limited to clinician-rated measures, language sampling tasks, combined measures of physiological data and observational behavioral data, eye-tracking, and electroencephalography paradigms.
All applicants and key collaborators must hold a Ph.D., M.D., or equivalent degree and have a faculty position or the equivalent at a college, university, medical school, or other research facility. Applications may be submitted by domestic and foreign nonprofit organizations; public and private institutions, such as colleges, universities, hospitals, laboratories, and units of state and local government; and eligible agencies of the federal government. There are no citizenship or national residence requirements.
See the Simons Foundation website for complete program guidelines and application instructions.
LOI Deadline: February 15, 2015
The mission of the Leukemia & Lymphoma Society is to find a cure for leukemia, lymphoma, Hodgkin’s disease, and myeloma and improve quality of life for patients and their families.
To advance these goals, the society’s Translational Research Program was developed to encourage and provide early support for leukemia, lymphoma, and myeloma clinical research projects that aim to develop innovative approaches to treatment, diagnosis, and prevention. The program is designed to support new research that demonstrates high promise for translating basic biomedical knowledge to clinical application. The goal of translational research is to reduce the time between laboratory findings and actual treatment.
Grants are limited to a maximum of $200,000 over three years.
To be eligible, applicants must hold an M.D., Ph.D., or equivalent degree and work at a domestic or foreign nonprofit organization such as a university, college, hospital, or laboratory.
Letters of Intent must be received no later than February 15, 2015. Upon review, selected applicants will be invited to submit full proposals by March 1, 2015.
For complete program guidelines and application procedures, see the LLS website.
Deadline: February 27, 2015, 4pm PST
The Nelly Auersperg Award in Women’s Health Research supports pilot studies in women’s health which aim to generate preliminary data, test new approaches, methodologies or tools. The funding supports activities that will enable the pursuit of more ambitious studies and foster further funding applications. This award is granted to a promising researcher in an area of women’s health to conduct an innovative research project (be it basic or applied science, using quantitative or qualitative methods on a topic related to women’s physical or mental health).
The amount awarded for this one-year grant is $10,000-$15,000.
At the time of application:
- Principal Applicants must be residents of BC
- Principal Applicant(s) must be an independent researcher/ clinician (includes midwives, nurses, social workers and physicians) and must have completed a post-graduate degree (Masters, PhD, or MD)
- Principal Applicants cannot be enrolled as students in a degree or diploma program and cannot hold positions as post-doctoral fellows, residents, or clinical fellows.
For application details, please visit http://whri.org/research-support/research-funding/NellyAuerspergAward.aspx
For questions about this award, please contact Kathryn Dewar by phone (604-875-2424 ext. 4956) or email (firstname.lastname@example.org).
LOI Deadline: May 15, 2015
The Friedreich’s Ataxia Research Alliance (FARA) is accepting Letters of Intent for the 2015 Phillip Bennett and Kyle Bryant Translational Research Award.
Grants of up to $500,000 over two years will be awarded in support of pre-clinical and clinical investigations that advance treatments for Friedreich’s ataxia, an autosomal recessive inherited disease which causes progressive damage to the nervous system. Projects must target one or more of the following areas: 1) the identification of biomarkers for FA that elucidate disease variability, severity, and prognosis; facilitate drug screening, and/or optimize selection of patients and clinical endpoints for clinical trials; 2) the development of tools and technologies that can be directly used for therapy development or to overcome existing obstacles to treatment and be directly applied to, or adapted for, delivery of potential therapeutics; 3) pre-clinical development and testing of potential therapeutics, biologics, and devices in cells and animals; and 4) clinical studies of patient outcome measures, potential interventions, and devices.
LOIs must be received no later than May 15, 2015. Upon review, selected applicants will be invited to submit complete applications by July 15, 2015.
Please visit the FARA website for further details.
Deadline: June 1, 2015
PSC Partners Seeking a Cure is a nonprofit foundation whose mission is to provide education and support to patients with primary sclerosing cholangitis, their families, and their caregivers and to raise funds to research causes, treatments, and cures for PSC, an autoimmune disease that causes the bile ducts inside and outside the liver to become scarred, narrowed, and eventually blocked.
The foundation offers grants of up to $60,000 over two years for research projects that address an important and novel basic or clinical research question related to PSC and closely allied diseases (such as inflammatory bowel diseases, ulcerative colitis, and Crohn’s disease) as they relate to PSC. Preference will be given to projects that have the potential to discover a cure for the disease and/or identify novel therapies that may significantly delay time to liver transplantation, prevent disease recurrence following liver transplantation, and/or improve the quality of life of those with PSC. Projects focused on assessing and improving the quality of life of PSC patients are also encouraged.
To be eligible, the applicant must be at an academic institution with an interest in pursuing PSC as an indication for treatment.
For complete program guidelines and application instructions, visit the PSC Partners Seeking a Cure website.
AWARDS AND HONOURS:
Nomination Deadline: January 31, 2015
The Michael Smith Foundation for Health Research (MSFHR) is pleased to open nominations for the sixth annual Aubrey J. Tingle Prize and Lecture.
This prize is given to a British Columbia clinician scientist or scholar practitioner whose work in health research is internationally recognized and has significant impact on advancing clinical or health services and policy research — as well as its uptake — to improve health and the health system in BC and globally.
MSFHR is proud to present the 2015 Aubrey J. Tingle Prize in partnership with LifeSciences BC for the first time in the award’s history. The prize will be presented April 16, 2015, as part of the 17th annual LifeSciences BC Awards.
The deadline for nominations is Saturday, January 31, 2015.
For more information or to nominate a candidate, please refer to the competition page
Nomination Deadline: May 1, 2015
This award is named for the former chair of the Central Examination Committee, Dr. Louis Levasseur, who for 26 years personified an unusual commitment to the objectives of Council. He embodied the qualities and accomplishments that precisely characterize both the activities and type of person whom the award is intended to honour.
It is presented annually to a current or former MCC Council, Committee or staff member, or to a person whose collaboration has contributed in an extraordinary manner to the vision and mission of
the Medical Council of Canada.
Nominations may be made by past or present members of the MCC, members of its constituent bodies or staff.
The nomination letter and two letters of reference from individuals who are knowledgeable of the MCC’s vision and mission and of the contribution of the candidate to those ends must be submitted electronically to email@example.com no later than May 1 of the current year. The nomination letter must outline in point form:
- the nature of the nominees contributions
- the impact of the nominee on the MCC and its mission and vision
- how the nominee’s achievements/activities have promoted the mission and vision of the MCC
For more information or to see the list of MCC Levasseur Award Past Recipients including the 2014 MCC Levasseur Recipient, please visit http://mcc.ca/about/awards-fellowships/louis-levasseaur-award/.
BC Cancer Agency Research Seminar – “Cancer Genomics: From Discovery to Clinic”
Date & Time: January 19, 2015; 2-3pm
Location: Diamond Family Lecture Theatre, BC Cancer Agency Research Centre, 675 W. 10th Ave., Vancouver
A special presentation by Dr. Elaine R. Mardis, PhD – “Cancer Genomics: From Discovery to Clinic”
Hosts: Dr. Sohrab Shah & Dr. Stephen Yip
UBC Department of Pathology & Laboratory Medicine
Please see attached Poster for further details.
Date & Time: January 20, 2015; 1-3pm
Location: Room 101, Michael Smith Laboratories, 2185 East Mall, Vancouver
Monika Michalska, Manager, Research Partnerships, from the NSERC-Ottawa office will be coming to UBC on Tuesday, Jan. 20th to give a presentation, meet with researchers and answer any questions related to the NSERC SPG program. This information session is scheduled for 1:00 pm – 3:00pm on Tuesday, Jan. 20th, and additional information is available on the event announcement webpage.
NOTE: Please note that registration for this Workshop is REQUIRED, and lunch will be provided.
Please also note:
SPARC will once again be offering a voluntary Internal Review process for interested applicants for the 2015 Strategic Project Grant competition. Full details and requirements for participating in this process are outlined on the following: SPARC SPG Internal Review webpage. Internal Reviews are intended to help applicants fine-tune their SPG proposals so they are as competitive and impactful as possible.
Note the SPG Internal Review Registration deadline is: Friday, February 13th (see the above IR webpage for full details).
If you have any questions, feel free to forward them to: firstname.lastname@example.org.
Date & Time: January 21, 2015; 6-8pm
Location: Paetzold Auditorium, Jim Pattison Pavilion, Vancouver General Hospital
- AJung Moon, PhD Candidate in Mechanical Engineering, Vanier Scholar, CARIS Lab ~ Robo-Ethics
- Nick Snow, Masters Candidate in Rehabilitation Sciences, Brain Behaviuor Lab ~ Robo-Wrist Rehabilitation
- Navid Shirzad, PhD Candidate in Biomedical Engineering, RREACH Lab ~ Rehabilitation Robotics
As interactive robots become substantially more accessible to the general public in the near future, one of the main concerns for designers is in implementing socially acceptable and ethical human-robot interaction for non-expert users. One approach to addressing this concern is to develop a robot that can take advantage of human moral decision making – much of which are suggested to be based on intuition and strongly connected with the emotional part of the human brain, rather than the rational part of the brain. In this talk, A. Jung will present the promising, yet cautionary, tales of the moral synergy robots and humans can create.
Free wine and cheese reception to follow
Please RSVP here.